(Q35005490)

English

Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

pharmacokinetics

1 reference

based on heuristic

inferred from title

Hans-Jürgen Stellbrink

3

object named as

Hans-Jürgen Stellbrink

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

7

object named as

Joseph Eron

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

François Raffi

5

object named as

François Raffi

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

author name string

Robin Wood

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Keikawus Arasteh

2

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Eugenio Teofilo

4

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Richard B Pollard

6

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Jane Yeo

8

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Judith Millard

9

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Mary Beth Wire

10

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Odin J Naderer

11

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Antimicrobial Agents and Chemotherapy

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

48

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

116-123

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

Pharmacokinetic interaction between amprenavir and delavirdine after multiple-dose administration in healthy volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

8 July 2018

Induction of P-glycoprotein and cytochrome P450 3A by HIV protease inhibitors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

8 July 2018

Safety profile and tolerability of amprenavir in the treatment of adult and pediatric patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

8 July 2018

In vivo effect of alpha(1)-acid glycoprotein on pharmacokinetics of amprenavir, a human immunodeficiency virus protease inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

8 July 2018

Pharmacokinetic and pharmacodynamic study of the human immunodeficiency virus protease inhibitor amprenavir after multiple oral dosing

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

8 July 2018

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

8 July 2018

The value of patient-reported adherence to antiretroviral therapy in predicting virologic and immunologic response. California Collaborative Treatment Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

8 July 2018

Effects of zidovudine treatment on the small intestinal mucosa in patients infected with the human immunodeficiency virus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

8 July 2018

Pharmacokinetics of GW433908, a prodrug of amprenavir, in healthy male volunteers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

26 October 2018

Methadone blood concentrations are decreased by the administration of abacavir plus amprenavir

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

26 October 2018

Physiological effects of HIV infection on human intestinal epithelial cells: an in vitro model for HIV enteropathy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=310156

26 October 2018

Predictors of virological rebound in HIV-1-infected patients initiating a protease inhibitor-containing regimen

1 reference

https://pubmed.ncbi.nlm.nih.gov/14693528

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1128/AAC.48.1.116-123.2004

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35005490&oldid=1986603888"